KidneyIntelX™ Clinical Decision Impact / Validation a

KidneyIntelX™ Clinical Decision Impact / Validation and Health Economic Data to be Presented at Upcoming Scientific Conferences

Four new data presentations, including late breaking clinical study data, underscores the value of KidneyIntelX testing in helping slow progression of chronic kidney disease in type 2 diabetes patientsLONDON and SALT LAKE CITY, June 15, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today announced that three scientific abstracts have been accepted at the upcoming American Diabetes Association 83rd Scientific Sessions (June 23-26, 2023) in San Diego, California and another abs

Related Keywords

United States , San Diego , California , University Of Illinois , Illinois , London , City Of , United Kingdom , New Orleans , Louisiana , Chicago , American , Joji Tokita , Karla Gonye , Kibum Kim , Ignacio Guerrero Ros , Girish Nadkarni , Scientific Sessions Of The American Diabetes Association , Drug Administration , York State Department Of Health , Division Of Data , American Diabetes Association , Centers For Disease , Exchange Commission , Professor Department Of Pharmacy Systems , Diabetic Kidney Disease In Veterans Health Administration , American Association Of Nurse Practitioners National Conference , Nasdaq , American Association Of Nurse Practitioner , Mount Sinai Health System , Large Integrated Health Care System , Charles Bronfman Institute Of Personalized Medicine System , Scientific Sessions , American Association , Nurse Practitioners National Conference , Diabetes Association , Risk Profiling , Large Integrated Health Care , Diabetic Kidney , Charles Bronfman Institute , Personalized Medicine System Chief , Digital Medicine , Arthur Fishberg Professor , Monday June , Diabetic Kidney Disease , Veterans Health , Assistant Professor Department , Pharmacy Systems , Sunday June , Nurse Practitioner , Patient Receptivity Towards Receipt , Prognostic Risk Score , Patient Care Navigation Team , Disease Control , Breakthrough Device Designation , New York State Department , Mount Sinai , Private Securities Litigation Reform Act , Lianne Applegarth ,

© 2025 Vimarsana